Hemodialysis & Peritoneal Dialysis Market by Product (Hemodialysis Equipment, Dialysates, PD Machine, Consumables), Modality (CAPD, APD, SDHD, Conventional HD, Nocturnal HD), Disease Indication (CKD, ESRD, AKI), End User, Region - Global Forecast to 2031
The global hemodialysis and peritoneal dialysis market was valued at USD 102.7 billion in 2026 and is expected to reach USD 141.5 billion by 2031, growing at a CAGR of 6.6% during the forecast period. Rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), driven by increasing rates of diabetes, hypertension, and aging populations worldwide, is the primary force behind market expansion. Growing adoption of home-based dialysis therapies, supported by cost-containment policies in healthcare systems and payer reimbursement frameworks such as the Centers for Medicare & Medicaid Services (CMS) in the US, is broadening the patient base for both home hemodialysis and peritoneal dialysis. Expanding dialysis infrastructure in emerging markets across Asia Pacific, Latin America, and the Middle East and Africa is further adding to global patient volumes. High treatment costs and poor reimbursement for home hemodialysis in several markets outside North America remain constraints on faster adoption of home-based modalities.
“The HD access products subsegment is expected to register the highest CAGR among HD consumables during the forecast period.”
Among the HD consumables and supplies segments, HD access products are projected to grow at the highest CAGR during the forecast period. Vascular access is a prerequisite for every hemodialysis session, and the structural demand it creates is consistent across care settings. Clinical guidelines from the National Kidney Foundation's KDOQI protocols, which prioritize arteriovenous fistula creation as the preferred access method, are driving procedure volumes and associated product consumption. The increasing use of tunneled hemodialysis catheters as a bridge to permanent access, the expanding patient population requiring long-term access management, and growing demand for single-use access needles and securement products are all contributing to this segment's growth. Dialyzers, the second-fastest-growing subsegment, are also benefiting from rising clinical adoption of high-flux and medium-cut-off membrane technologies that improve middle-molecule clearance relative to standard membranes.
“Hospitals accounted for the largest share of the global hemodialysis and peritoneal dialysis market in 2025.”
By end user, hospitals held the largest share of the global hemodialysis and peritoneal dialysis market in 2025. Hospital-based dialysis units manage the full clinical complexity of the ESRD and AKI patient population, including newly diagnosed patients, those with significant comorbidities, and critical care patients requiring continuous renal replacement therapy. The concentration of specialized nephrology staff, dialysis equipment, and emergency infrastructure within hospital settings makes them the default point of care for patients initiating treatment. Independent dialysis centers collectively represent the largest channel but are distributed across a fragmented operator landscape, while hospitals manage a disproportionate share of high-acuity and newly incident patients. Home care settings are growing at the fastest rate among end users, driven by cost pressures in the healthcare system and the expansion of home dialysis program infrastructure.
“North America accounted for the largest share of the global hemodialysis and peritoneal dialysis market in 2025, while Asia Pacific is expected to register the highest CAGR during the forecast period.”
North America accounted for the largest share of the global hemodialysis and peritoneal dialysis market in 2025. The US is the primary driver within this region, supported by a large and structurally growing ESRD patient population of more than 808,000 individuals, according to the United States Renal Data System 2023 Annual Data Report. A mature reimbursement framework under the Medicare ESRD Prospective Payment System, which covers dialysis services at a finalized base rate of USD 281.71 per treatment for calendar year 2026, provides consistent revenue visibility for both product suppliers and service operators. The region is also home to a concentrated network of dialysis facilities, with approximately 7,600 CMS-recognized ESRD centers and major global industry participants. Asia Pacific is the fastest-growing regional market. China and India are the primary growth engines, with government-backed universal CKD coverage programs and subsidized dialysis access schemes accelerating patient enrollment at dialysis centers in both countries.
In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the hemodialysis and peritoneal dialysis market.
Study Coverage: This research report categorizes the global hemodialysis and peritoneal dialysis market by product and service (hemodialysis market and peritoneal dialysis market), HD product & service (HD machines, HD consumables & supplies, and HD services), HD machine type (center-use HD machines and home-use HD machines), HD consumables type (dialyzers, bloodlines sets & tubes, hemodialysis concentrates/dialysates, HD access products, and others), HD service type (in-center hemodialysis services and home hemodialysis (HHD) services), PD product & service (PD concentrates/dialysates, PD machines, PD catheters, PD transfer sets, other PD products, and PD services), HD modality (conventional long-term hemodialysis, short daily hemodialysis, and nocturnal hemodialysis), PD modality [continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD)], disease indication (end-stage renal disease (ESRD), acute kidney injury (AKI), and others), end user (hospitals, independent dialysis centers, home care settings, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The report provides detailed information on the key factors driving growth in the global hemodialysis and peritoneal dialysis markets.
Key Benefits of Buying this Report
“The HD access products subsegment is expected to register the highest CAGR among HD consumables during the forecast period.”
Among the HD consumables and supplies segments, HD access products are projected to grow at the highest CAGR during the forecast period. Vascular access is a prerequisite for every hemodialysis session, and the structural demand it creates is consistent across care settings. Clinical guidelines from the National Kidney Foundation's KDOQI protocols, which prioritize arteriovenous fistula creation as the preferred access method, are driving procedure volumes and associated product consumption. The increasing use of tunneled hemodialysis catheters as a bridge to permanent access, the expanding patient population requiring long-term access management, and growing demand for single-use access needles and securement products are all contributing to this segment's growth. Dialyzers, the second-fastest-growing subsegment, are also benefiting from rising clinical adoption of high-flux and medium-cut-off membrane technologies that improve middle-molecule clearance relative to standard membranes.
“Hospitals accounted for the largest share of the global hemodialysis and peritoneal dialysis market in 2025.”
By end user, hospitals held the largest share of the global hemodialysis and peritoneal dialysis market in 2025. Hospital-based dialysis units manage the full clinical complexity of the ESRD and AKI patient population, including newly diagnosed patients, those with significant comorbidities, and critical care patients requiring continuous renal replacement therapy. The concentration of specialized nephrology staff, dialysis equipment, and emergency infrastructure within hospital settings makes them the default point of care for patients initiating treatment. Independent dialysis centers collectively represent the largest channel but are distributed across a fragmented operator landscape, while hospitals manage a disproportionate share of high-acuity and newly incident patients. Home care settings are growing at the fastest rate among end users, driven by cost pressures in the healthcare system and the expansion of home dialysis program infrastructure.
“North America accounted for the largest share of the global hemodialysis and peritoneal dialysis market in 2025, while Asia Pacific is expected to register the highest CAGR during the forecast period.”
North America accounted for the largest share of the global hemodialysis and peritoneal dialysis market in 2025. The US is the primary driver within this region, supported by a large and structurally growing ESRD patient population of more than 808,000 individuals, according to the United States Renal Data System 2023 Annual Data Report. A mature reimbursement framework under the Medicare ESRD Prospective Payment System, which covers dialysis services at a finalized base rate of USD 281.71 per treatment for calendar year 2026, provides consistent revenue visibility for both product suppliers and service operators. The region is also home to a concentrated network of dialysis facilities, with approximately 7,600 CMS-recognized ESRD centers and major global industry participants. Asia Pacific is the fastest-growing regional market. China and India are the primary growth engines, with government-backed universal CKD coverage programs and subsidized dialysis access schemes accelerating patient enrollment at dialysis centers in both countries.
In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the hemodialysis and peritoneal dialysis market.
- By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
- By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
- By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)
Study Coverage: This research report categorizes the global hemodialysis and peritoneal dialysis market by product and service (hemodialysis market and peritoneal dialysis market), HD product & service (HD machines, HD consumables & supplies, and HD services), HD machine type (center-use HD machines and home-use HD machines), HD consumables type (dialyzers, bloodlines sets & tubes, hemodialysis concentrates/dialysates, HD access products, and others), HD service type (in-center hemodialysis services and home hemodialysis (HHD) services), PD product & service (PD concentrates/dialysates, PD machines, PD catheters, PD transfer sets, other PD products, and PD services), HD modality (conventional long-term hemodialysis, short daily hemodialysis, and nocturnal hemodialysis), PD modality [continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD)], disease indication (end-stage renal disease (ESRD), acute kidney injury (AKI), and others), end user (hospitals, independent dialysis centers, home care settings, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The report provides detailed information on the key factors driving growth in the global hemodialysis and peritoneal dialysis markets.
Key Benefits of Buying this Report
- Analysis of Key Drivers, Restraints, Opportunities, and Challenges: Gain insights into the principal factors shaping the global hemodialysis and peritoneal dialysis market, including rising CKD and ESRD prevalence, expanding home dialysis adoption, favorable reimbursement policies, high treatment costs, poor home HD reimbursement in select markets, digital health integration opportunities, and patient compliance challenges.
- Market Development: Understand current and projected market sizes across all product, service, modality, disease indication, end-user, and regional segments from 2024 to 2031, with base year data for 2025 and a complete historical series from 2024.
- Market Diversification: Identify high-growth pockets including HD access products, home hemodialysis services, home care settings, and the Asia Pacific regional market, along with country-level breakdowns for 20+ markets.
- Competitive Assessment: Evaluate the competitive positioning of key players including Fresenius Medical Care, Vantive, B. Braun, Nipro Corporation, Nikkiso Co., Ltd., DaVita Inc., Asahi Kasei Medical Co., Ltd., Toray Medical Co., Ltd., JMS Co., Ltd., Outset Medical, and Rockwell Medical, with analysis of their product portfolios, strategies, and recent commercial developments.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.4 INCLUSIONS AND EXCLUSIONS
1.4.1 YEARS CONSIDERED
1.4.2 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 LIMITATIONS
1.7 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET OVERVIEW
3.2 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER AND COUNTRY (2025)
3.3 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COUNTRY/REGION
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Rising prevalence of chronic kidney disease and end-stage renal disease
4.2.1.2 Increasing aging population susceptible to kidney disorders
4.2.1.3 Growing prevalence of diabetes and hypertension
4.2.1.4 Continuous technological advancements in dialysis machines and consumables
4.2.2 RESTRAINTS
4.2.2.1 High cost of dialysis treatment and infrastructure
4.2.2.2 Frequent product recalls and quality compliance issues
4.2.3 OPPORTUNITIES
4.2.3.1 Expansion of dialysis centers and renal care infrastructure
4.2.3.2 Investments in healthcare infrastructure in emerging markets
4.2.4 CHALLENGES
4.2.4.1 Shortage of nephrologists and trained dialysis professionals
4.2.4.2 Risk of dialysis-related infections and complications
4.3 UNMET NEEDS AND WHITE SPACES
4.3.1 UNMET NEEDS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
4.5.1 STRATEGIC MOVES IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF SUPPLIERS
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.5.1 MANUFACTURERS
5.5.2 END USERS
5.5.3 REGULATORY BODIES
5.6 PRICING ANALYSIS
5.7 TRADE ANALYSIS
5.7.1 IMPORT DATA (HS CODE 9018)
5.7.2 EXPORT DATA FOR (HS CODE 9018)
5.8 REIMBURSEMENT SCENARIO
5.9 KEY CONFERENCES AND EVENTS, 2026–2027
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.11 INVESTMENT AND FUNDING SCENARIO
5.12 CASE STUDY ANALYSIS
5.13 IMPACT OF 2025 US TARIFF - HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
5.13.1 INTRODUCTION
5.13.2 KEY TARIFF RATES
5.13.3 PRICE IMPACT ANALYSIS
5.13.4 IMPACT ON COUNTRIES/REGIONS
5.13.5 IMPACT ON END-USE SEGMENTS
5.13.5.1 Hospitals
5.13.5.2 Independent dialysis centers
5.13.5.3 Home care settings
5.13.5.4 Other end users
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 TECHNOLOGY ANALYSIS
6.1.1 KEY EMERGING TECHNOLOGIES
6.1.1.1 High-volume hemodiafiltration (HDF)
6.1.1.2 Intelligent home dialysis platforms
6.1.2 COMPLEMENTARY TECHNOLOGIES
6.1.2.1 Remote patient management platforms
6.1.2.2 Advanced dialyzer membrane technology
6.1.3 ADJACENT TECHNOLOGIES
6.1.3.1 Portable & wearable artificial kidney technologies
6.2 TECHNOLOGY/PRODUCT ROADMAP
6.2.1 NEAR TERM (2025–2027)
6.2.2 MID-TERM (2028–2030)
6.2.3 LONG TERM (2030+)
6.3 PATENT ANALYSIS
6.3.1 JURISDICTION AND TOP APPLICANT ANALYSIS
6.4 FUTURE APPLICATIONS
6.4.1 AI-ASSISTED TREATMENT PLANNING AND THERAPY OPTIMIZATION
6.4.2 PERSONALIZED DIALYSIS THERAPY
6.4.3 CONNECTED DIALYSIS WORKFLOWS AND DIGITAL INTEGRATION
6.5 IMPACT OF AI/GEN AI ON HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
6.5.1 INTRODUCTION
6.5.2 MARKET POTENTIAL OF AI IN HEMODIALYSIS AND PERITONEAL DIALYSIS
6.5.3 AI USE CASES
6.5.4 KEY COMPANIES IMPLEMENTING AI
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
7.1 REGULATORY LANDSCAPE
7.1.1 REGULATORY FRAMEWORK
7.1.1.1 North America
7.1.1.2 Europe
7.1.1.3 Asia Pacific
7.1.1.4 Latin America
7.1.1.5 Middle East & Africa
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.3 INDUSTRY STANDARDS
7.2 SUSTAINABILITY INITIATIVES
7.2.1 REDUCING MEDICAL WASTE & USE OF LOWER-IMPACT MATERIALS AND PACKAGING
7.2.2 WATER, ENERGY, & RESOURCE EFFICIENCY
7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
9 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE
9.1 INTRODUCTION
9.2 HEMODIALYSIS SERVICES
9.2.1 IN—CENTER HEMODIALYSIS SERVICES
9.2.1.1 Growing geriatric population and increasing government healthcare expenditure to drive segment
9.2.2 HOME HEMODIALYSIS SERVICES
9.2.2.1 Poor reimbursement scenario and high treatment costs to limit market growth
9.3 HEMODIALYSIS PRODUCTS
9.3.1 HEMODIALYSIS MACHINES
9.3.1.1 Center-use hemodialysis machines
9.3.1.1.1 Rising number of renal care centers to aid segment growth
9.3.1.1.2 Volume analysis of center-use hemodialysis machines, 2024–2031 (ten thousand units)
9.3.1.2 Home-use hemodialysis machines
9.3.1.2.1 Lesser hospital stays and better clinical outcomes to propel segment growth
9.3.1.2.2 Volume analysis of home-use hemodialysis machines, 2024–2031 (ten thousand units)
9.3.2 HEMODIALYSIS CONSUMABLES & SUPPLIES
9.3.2.1 Dialyzers
9.3.2.1.1 Dialyzers market, by material
9.3.2.1.1.1 Synthetic dialyzers
9.3.2.1.1.1.1 High physical strength and increased chemical resistance to drive segment
9.3.2.1.1.1.2 Volume analysis of synthetic dialyzers, 2024-2031 (Ten Thousand Units)
9.3.2.1.1.2 Cellulose-based dialyzers
9.3.2.1.1.2.1 Affordability and high biocompatibility to support segment growth
9.3.2.1.1.2.2 volume analysis of cellulose-based dialyzers, 2024-2031 (ten thousand units)
9.3.2.1.2 Dialyzers market, by flux
9.3.2.1.2.1 High-flux dialyzers
9.3.2.1.2.1.1 High-flux dialyzers to command larger market share during forecast period
9.3.2.1.2.1.2 Volume analysis of high-flux dialyzers, 2024-2031 (Ten Thousand units)
9.3.2.1.2.2 Low-flux dialyzers
9.3.2.1.2.2.1 Ability to filter small toxin particles to propel segment growth
9.3.2.1.2.2.2 Volume analysis of low-flux dialyzers, 2024-2031 (Ten Thousand Units)
9.3.2.2 Bloodline sets and tubes
9.3.2.2.1 High pricing and reduced rate of reuse to limit market expansion
9.3.2.2.2 Volume analysis of bloodline sets and tubes, 2024-2031 (Ten Thousand Units)
9.3.2.3 Concentrates/Dialysates
9.3.2.3.1 Alkaline concentrates
9.3.2.3.1.1 Growing consumption before dialysis to boost segment growth
9.3.2.3.1.2 Volume analysis of alkaline concentrates, 2024-2031 (Ten Thousand Units)
9.3.2.3.2 Acidic concentrates
9.3.2.3.2.1 Increased number of side effects to limit segment growth
9.3.2.3.2.2 Volume analysis of acidic concentrates, 2024-2031 (Ten Thousand Units)
9.3.2.4 Access products
9.3.2.4.1 AV fistula needles
9.3.2.4.1.1 Better blood flow and lower infection risk to aid segment growth
9.3.2.4.2 AV grafts
9.3.2.4.2.1 Increased number of patients requiring long-term dialysis to support segment growth
9.3.2.4.3 Central venous catheters
9.3.2.4.3.1 Increased use in temporary vascular access for short-term dialysis to boost segment growth
9.3.2.5 Other hemodialysis consumables & supplies
9.3.2.5.1 Volume analysis of other hemodialysis consumables, 2024-2031 (Ten Thousand Units)
9.4 HEMODIALYSIS MARKET, BY MODALITY
9.4.1 CONVENTIONAL HEMODIALYSIS
9.4.1.1 Technological advancements and rising number of dialysis centers to drive segment
9.4.2 SHORT DAILY HEMODIALYSIS
9.4.2.1 Improved blood pressure control and better calcium-phosphorus balance to augment segment growth
9.4.3 NOCTURNAL HEMODIALYSIS
9.4.3.1 Lower procedure costs to aid segment growth
9.5 HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, BY TYPE
9.5.1 CENTRAL WATER DISINFECTION SYSTEMS
9.5.1.1 Cost-effectiveness and easy maintenance to drive market
9.5.1.1.1 Volume analysis of central water disinfection systems, 2024-2031 (Ten Thousand Units)
9.5.2 PORTABLE WATER DISINFECTION SYSTEMS
9.5.2.1 User-friendly operations and improved microbiological purity to support segment growth
9.5.2.1.1 Volume analysis of portable water disinfection systems, 2024-2031 (Ten Thousand Units)
10 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE
10.1 INTRODUCTION
10.2 PERITONEAL DIALYSIS PRODUCTS
10.2.1 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES
10.2.1.1 High demand for concentrates to boost segment growth
10.2.1.1.1 Volume analysis of peritoneal dialysis concentrates/ dialysates, 2024-2031 (Ten Thousand Units)
10.2.2 PERITONEAL DIALYSIS MACHINES
10.2.2.1 Rising prevalence of chronic diseases in emerging economies to boost adoption
10.2.2.1.1 Volume analysis of peritoneal dialysis machines, 2024-2031 (Ten Thousand Units)
10.2.3 PERITONEAL DIALYSIS CATHETERS
10.2.3.1 Favorable reimbursement policies to support market growth
10.2.3.1.1 Volume analysis of peritoneal dialysis catheters, 2024-2031 (Ten Thousand Units)
10.2.4 PERITONEAL DIALYSIS TRANSFER SETS
10.2.4.1 Increasing number of patients in emerging economies to aid market growth
10.2.4.1.1 Volume analysis of peritoneal dialysis transfer sets, 2024-2031 (Ten Thousand Units)
10.2.5 OTHER PERITONEAL DIALYSIS PRODUCTS
10.2.5.1 Volume analysis of other peritoneal dialysis products, 2024-2031 (Ten Thousand Units)
10.3 PERITONEAL DIALYSIS SERVICES
10.3.1 BETTER PRIVACY AND INCREASED COMFORT OF AT-HOME DIALYSIS TREATMENT TO DRIVE MARKET
10.4 PERITONEAL DIALYSIS MARKET, BY MODALITY
10.4.1 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
10.4.1.1 Superior clearance of high-molecular-weight substances to drive market
10.4.2 AUTOMATED PERITONEAL DIALYSIS
10.4.2.1 Risk of rapid decline in residual renal functions to limit adoption
11 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION
11.1 INTRODUCTION
11.2 END-STAGE RENAL DISEASE
11.2.1 RISING GERIATRIC POPULATION AND INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET
11.3 ACUTE KIDNEY INJURY
11.3.1 INCREASING NUMBER OF HOSPITALIZATIONS TO PROPEL MARKET GROWTH
11.4 OTHER INDICATIONS
12 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER
12.1 INTRODUCTION
12.2 HOSPITALS
12.2.1 IMPROVED FACILITIES AND INCREASED GOVERNMENT SUPPORT TO DRIVE MARKET
12.3 INDEPENDENT DIALYSIS CENTERS
12.3.1 INCREASED DEMAND FOR ADVANCED DIALYSIS AND END-STAGE RENAL DISEASE TREATMENTS TO PROPEL MARKET GROWTH
12.4 HOME CARE SETTINGS
12.4.1 LOWER COST AND SHORTER HOSPITAL STAYS TO AID MARKET GROWTH
12.5 OTHER END USERS
13 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION
13.1 INTRODUCTION
13.2 NORTH AMERICA
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
13.2.2 NORTH AMERICA: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031
13.2.3 US
13.2.3.1 US to dominate North American market during study period
13.2.4 CANADA
13.2.4.1 Shortage of dialysis facilities and increased treatment cost to restrain market expansion
13.3 EUROPE
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
13.3.2 EUROPE: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031
13.3.3 GERMANY
13.3.3.1 Rising number of end-stage renal disease patients to boost market growth
13.3.4 UK
13.3.4.1 Expanding home dialysis programs and strong NHS support to drive market
13.3.5 FRANCE
13.3.5.1 Strong reimbursement framework and growing home dialysis adoption to fuel market
13.3.6 ITALY
13.3.6.1 Universal healthcare coverage and rising CKD burden to support market growth
13.3.7 SPAIN
13.3.7.1 Increasing CKD prevalence and expanding renal care infrastructure to drive market
13.3.8 REST OF EUROPE
13.4 ASIA PACIFIC
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
13.4.2 ASIA PACIFIC: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031
13.4.3 CHINA
13.4.3.1 Expanding dialysis infrastructure and large CKD patient base to drive market
13.4.4 JAPAN
13.4.4.1 Advanced dialysis infrastructure and universal reimbursement to support market growth
13.4.5 INDIA
13.4.5.1 Government-led dialysis expansion and rising CKD burden to fuel market
13.4.6 AUSTRALIA
13.4.6.1 High adoption of home dialysis and strong healthcare system to support market growth
13.4.7 SOUTH KOREA
13.4.7.1 Growing CKD burden and expanding renal care services to drive market
13.4.8 REST OF ASIA PACIFIC
13.5 LATIN AMERICA
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
13.5.2 LATIN AMERICA: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031
13.5.3 BRAZIL
13.5.3.1 Large dialysis patient base and expanding renal care infrastructure to drive market
13.5.4 MEXICO
13.5.4.1 Healthcare reforms and expanding access to dialysis to support market growth
13.5.5 REST OF LATIN AMERICA
13.6 MIDDLE EAST & AFRICA
13.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
13.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031
13.6.3 GCC COUNTRIES
13.6.3.1 Kingdom of Saudi Arabia (KSA)
13.6.3.1.1 Saudi Vision 2030 and expanding dialysis infrastructure to drive market
13.6.3.2 United Arab Emirates (UAE)
13.6.3.2.1 Growing investments in renal care and rising CKD burden to support market growth
13.6.3.3 Other GCC countries
13.6.4 REST OF MIDDLE EAST & AFRICA
14 COMPETITIVE LANDSCAPE
14.1 OVERVIEW
14.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023–JUNE 2026
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
14.3 REVENUE ANALYSIS
14.4 MARKET SHARE ANALYSIS
14.4.1 GLOBAL HEMODIALYSIS MARKET SHARE ANALYSIS, 2025
14.4.1.1 US hemodialysis market share analysis, 2025
14.4.1.2 Europe hemodialysis market share analysis, 2025
14.4.2 GLOBAL PERITONEAL DIALYSIS MARKET SHARE ANALYSIS, 2025
14.4.2.1 US peritoneal dialysis market share analysis, 2025
14.4.2.2 Europe peritoneal dialysis market share analysis, 2025
14.5 BRAND/PRODUCT COMPARISON
14.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
14.6.1 STARS
14.6.2 EMERGING LEADERS
14.6.3 PERVASIVE PLAYERS
14.6.4 PARTICIPANTS
14.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
14.6.5.1 Company footprint
14.6.5.2 Region footprint
14.6.5.3 Hemodialysis product & service footprint
14.6.5.4 Hemodialysis modality footprint
14.6.5.5 Hemodialysis water treatment system type footprint
14.6.5.6 Peritoneal dialysis product & service footprint
14.6.5.7 Peritoneal dialysis modality footprint
14.6.5.8 Hemodialysis and peritoneal dialysis application footprint
14.6.5.9 Hemodialysis and peritoneal dialysis end user footprint
14.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
14.7.1 PROGRESSIVE COMPANIES
14.7.2 RESPONSIVE COMPANIES
14.7.3 DYNAMIC COMPANIES
14.7.4 STARTING BLOCKS
14.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
14.7.5.1 Detailed list of key startups/SMEs
14.7.5.2 Competitive benchmarking of key startups/SMEs
14.8 COMPANY VALUATION AND FINANCIAL METRICS
14.8.1 COMPANY VALUATION
14.8.2 FINANCIAL METRICS
14.9 COMPETITIVE SCENARIO
14.9.1 PRODUCT LAUNCHES & APPROVALS
14.9.2 DEALS
14.9.3 EXPANSIONS
14.9.4 OTHER DEVELOPMENTS
15 COMPANY PROFILES
15.1 KEY PLAYERS
15.1.1 FRESENIUS MEDICAL CARE AG
15.1.1.1 Business overview
15.1.1.2 Products/Solutions/Services offered
15.1.1.3 Recent developments
15.1.1.3.1 Product launches & approvals
15.1.1.3.2 Deals
15.1.1.3.3 Expansions
15.1.1.3.4 Other developments
15.1.1.4 MnM view
15.1.1.4.1 Key strengths
15.1.1.4.2 Strategic choices
15.1.1.4.3 Weaknesses & competitive threats
15.1.2 DAVITA INC.
15.1.2.1 Business overview
15.1.2.2 Products/Solutions/Services offered
15.1.2.3 Recent developments
15.1.2.3.1 Deals
15.1.2.4 MnM view
15.1.2.4.1 Key strengths
15.1.2.4.2 Strategic choices
15.1.2.4.3 Weaknesses & competitive threats
15.1.3 VANTIVE
15.1.3.1 Business overview
15.1.3.2 Products/Solutions/Services offered
15.1.3.3 Recent developments
15.1.3.3.1 Product launches & approvals
15.1.3.3.2 Deals
15.1.3.3.3 Expansions
15.1.3.3.4 Other developments
15.1.3.4 MnM view
15.1.3.4.1 Key strengths
15.1.3.4.2 Strategic choices
15.1.3.4.3 Weaknesses & competitive threats
15.1.4 U.S. RENAL CARE, INC.
15.1.4.1 Business overview
15.1.4.2 Products/Solutions/Services offered
15.1.4.3 MnM view
15.1.4.3.1 Key strengths
15.1.4.3.2 Strategic choices
15.1.4.3.3 Weaknesses & competitive threats
15.1.5 B. BRAUN SE
15.1.5.1 Business overview
15.1.5.2 Products/Solutions/Services offered
15.1.5.3 Recent developments
15.1.5.3.1 Expansions
15.1.5.4 MnM view
15.1.5.4.1 Key strengths
15.1.5.4.2 Strategic choices
15.1.5.4.3 Weaknesses & competitive threats
15.1.6 NIPRO CORPORATION
15.1.6.1 Business overview
15.1.6.2 Products/Solutions/Services offered
15.1.6.3 Recent developments
15.1.6.3.1 Product launches & approvals
15.1.6.3.2 Deals
15.1.6.3.3 Expansions
15.1.7 DIAVERUM AB
15.1.7.1 Business overview
15.1.7.2 Products/Solutions/Services offered
15.1.7.3 Recent developments
15.1.7.3.1 Deals
15.1.7.3.2 Expansions
15.1.8 ASAHI KASEI MEDICAL CO., LTD.
15.1.8.1 Business overview
15.1.8.2 Products/Solutions/Services offered
15.1.8.3 Recent developments
15.1.8.3.1 Deals
15.1.8.3.2 Other developments
15.1.9 TORAY INDUSTRIES, INC.
15.1.9.1 Business overview
15.1.9.2 Products/Solutions/Services offered
15.1.10 NIKKISO CO., LTD.
15.1.10.1 Business overview
15.1.10.2 Products/Solutions/Services offered
15.1.10.3 Recent developments
15.1.10.3.1 Product launches & approvals
15.1.10.3.2 Deals
15.1.11 MOZARC MEDICAL
15.1.11.1 Business overview
15.1.11.2 Products/Solutions/Services offered
15.1.11.3 Recent developments
15.1.11.3.1 Deals
15.1.12 BD
15.1.12.1 Business overview
15.1.12.2 Products/Solutions/Services offered
15.1.12.3 Recent developments
15.1.12.3.1 Deals
15.1.12.3.2 Expansions
15.1.13 JMS CO., LTD.
15.1.13.1 Business overview
15.1.13.2 Products/Solutions/Services offered
15.1.14 MERIT MEDICAL SYSTEMS
15.1.14.1 Business overview
15.1.14.2 Products/Solutions/Services offered
15.1.14.3 Recent developments
15.1.14.3.1 Deals
15.1.15 TERUMO CORPORATION
15.1.15.1 Business overview
15.1.15.2 Products/Solutions/Services offered
15.2 OTHER PLAYERS
15.2.1 ALLMED MEDICAL PRODUCTS CO., LTD.
15.2.2 OUTSET MEDICAL, INC.
15.2.3 ROCKWELL MEDICAL, INC.
15.2.4 AMERIWATER LLC
15.2.5 DIALIFE SA
15.2.6 QUANTA DIALYSIS TECHNOLOGIES LTD
15.2.7 ISOPURE CORP.
15.2.8 POLY MEDICURE LIMITED
15.2.9 ATLANTIC BIOMEDICAL
15.2.10 AMECATH
16 RESEARCH METHODOLOGY
16.1 RESEARCH DATA
16.1.1 SECONDARY DATA
16.1.1.1 Key secondary sources
16.1.2 PRIMARY DATA
16.1.2.1 Primary sources
16.1.2.2 Key data from primary sources
16.1.2.3 Key industry insights
16.1.2.4 Breakdown of primaries
16.2 MARKET SIZE ESTIMATION
16.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
16.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
16.2.3 APPROACH 3: TOP-DOWN APPROACH
16.2.4 APPROACH 4: BOTTOM-UP APPROACH
16.2.5 APPROACH 4: PRIMARY INTERVIEWS
16.2.6 APPROACH 5: DEMAND-SIDE APPROACH
16.2.7 APPROACH 6: VOLUME DATA ANALYSIS
16.3 DATA TRIANGULATION AND MARKET BREAKDOWN
16.4 MARKET SHARE ASSESSMENT
16.5 RESEARCH ASSUMPTIONS
16.5.1 STUDY ASSUMPTIONS
16.5.2 GROWTH RATE ASSUMPTIONS
16.6 RISK ASSESSMENT
16.7 RESEARCH LIMITATIONS
17 APPENDIX
17.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.2 CUSTOMIZATION OPTIONS
17.2.1 PRODUCT ANALYSIS
17.2.2 COMPANY INFORMATION
17.2.3 GEOGRAPHIC ANALYSIS
17.3 RELATED REPORTS
17.4 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.4 INCLUSIONS AND EXCLUSIONS
1.4.1 YEARS CONSIDERED
1.4.2 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 LIMITATIONS
1.7 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET OVERVIEW
3.2 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER AND COUNTRY (2025)
3.3 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COUNTRY/REGION
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Rising prevalence of chronic kidney disease and end-stage renal disease
4.2.1.2 Increasing aging population susceptible to kidney disorders
4.2.1.3 Growing prevalence of diabetes and hypertension
4.2.1.4 Continuous technological advancements in dialysis machines and consumables
4.2.2 RESTRAINTS
4.2.2.1 High cost of dialysis treatment and infrastructure
4.2.2.2 Frequent product recalls and quality compliance issues
4.2.3 OPPORTUNITIES
4.2.3.1 Expansion of dialysis centers and renal care infrastructure
4.2.3.2 Investments in healthcare infrastructure in emerging markets
4.2.4 CHALLENGES
4.2.4.1 Shortage of nephrologists and trained dialysis professionals
4.2.4.2 Risk of dialysis-related infections and complications
4.3 UNMET NEEDS AND WHITE SPACES
4.3.1 UNMET NEEDS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
4.5.1 STRATEGIC MOVES IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF SUPPLIERS
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.5.1 MANUFACTURERS
5.5.2 END USERS
5.5.3 REGULATORY BODIES
5.6 PRICING ANALYSIS
5.7 TRADE ANALYSIS
5.7.1 IMPORT DATA (HS CODE 9018)
5.7.2 EXPORT DATA FOR (HS CODE 9018)
5.8 REIMBURSEMENT SCENARIO
5.9 KEY CONFERENCES AND EVENTS, 2026–2027
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.11 INVESTMENT AND FUNDING SCENARIO
5.12 CASE STUDY ANALYSIS
5.13 IMPACT OF 2025 US TARIFF - HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
5.13.1 INTRODUCTION
5.13.2 KEY TARIFF RATES
5.13.3 PRICE IMPACT ANALYSIS
5.13.4 IMPACT ON COUNTRIES/REGIONS
5.13.5 IMPACT ON END-USE SEGMENTS
5.13.5.1 Hospitals
5.13.5.2 Independent dialysis centers
5.13.5.3 Home care settings
5.13.5.4 Other end users
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 TECHNOLOGY ANALYSIS
6.1.1 KEY EMERGING TECHNOLOGIES
6.1.1.1 High-volume hemodiafiltration (HDF)
6.1.1.2 Intelligent home dialysis platforms
6.1.2 COMPLEMENTARY TECHNOLOGIES
6.1.2.1 Remote patient management platforms
6.1.2.2 Advanced dialyzer membrane technology
6.1.3 ADJACENT TECHNOLOGIES
6.1.3.1 Portable & wearable artificial kidney technologies
6.2 TECHNOLOGY/PRODUCT ROADMAP
6.2.1 NEAR TERM (2025–2027)
6.2.2 MID-TERM (2028–2030)
6.2.3 LONG TERM (2030+)
6.3 PATENT ANALYSIS
6.3.1 JURISDICTION AND TOP APPLICANT ANALYSIS
6.4 FUTURE APPLICATIONS
6.4.1 AI-ASSISTED TREATMENT PLANNING AND THERAPY OPTIMIZATION
6.4.2 PERSONALIZED DIALYSIS THERAPY
6.4.3 CONNECTED DIALYSIS WORKFLOWS AND DIGITAL INTEGRATION
6.5 IMPACT OF AI/GEN AI ON HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
6.5.1 INTRODUCTION
6.5.2 MARKET POTENTIAL OF AI IN HEMODIALYSIS AND PERITONEAL DIALYSIS
6.5.3 AI USE CASES
6.5.4 KEY COMPANIES IMPLEMENTING AI
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
7.1 REGULATORY LANDSCAPE
7.1.1 REGULATORY FRAMEWORK
7.1.1.1 North America
7.1.1.2 Europe
7.1.1.3 Asia Pacific
7.1.1.4 Latin America
7.1.1.5 Middle East & Africa
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.3 INDUSTRY STANDARDS
7.2 SUSTAINABILITY INITIATIVES
7.2.1 REDUCING MEDICAL WASTE & USE OF LOWER-IMPACT MATERIALS AND PACKAGING
7.2.2 WATER, ENERGY, & RESOURCE EFFICIENCY
7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
9 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE
9.1 INTRODUCTION
9.2 HEMODIALYSIS SERVICES
9.2.1 IN—CENTER HEMODIALYSIS SERVICES
9.2.1.1 Growing geriatric population and increasing government healthcare expenditure to drive segment
9.2.2 HOME HEMODIALYSIS SERVICES
9.2.2.1 Poor reimbursement scenario and high treatment costs to limit market growth
9.3 HEMODIALYSIS PRODUCTS
9.3.1 HEMODIALYSIS MACHINES
9.3.1.1 Center-use hemodialysis machines
9.3.1.1.1 Rising number of renal care centers to aid segment growth
9.3.1.1.2 Volume analysis of center-use hemodialysis machines, 2024–2031 (ten thousand units)
9.3.1.2 Home-use hemodialysis machines
9.3.1.2.1 Lesser hospital stays and better clinical outcomes to propel segment growth
9.3.1.2.2 Volume analysis of home-use hemodialysis machines, 2024–2031 (ten thousand units)
9.3.2 HEMODIALYSIS CONSUMABLES & SUPPLIES
9.3.2.1 Dialyzers
9.3.2.1.1 Dialyzers market, by material
9.3.2.1.1.1 Synthetic dialyzers
9.3.2.1.1.1.1 High physical strength and increased chemical resistance to drive segment
9.3.2.1.1.1.2 Volume analysis of synthetic dialyzers, 2024-2031 (Ten Thousand Units)
9.3.2.1.1.2 Cellulose-based dialyzers
9.3.2.1.1.2.1 Affordability and high biocompatibility to support segment growth
9.3.2.1.1.2.2 volume analysis of cellulose-based dialyzers, 2024-2031 (ten thousand units)
9.3.2.1.2 Dialyzers market, by flux
9.3.2.1.2.1 High-flux dialyzers
9.3.2.1.2.1.1 High-flux dialyzers to command larger market share during forecast period
9.3.2.1.2.1.2 Volume analysis of high-flux dialyzers, 2024-2031 (Ten Thousand units)
9.3.2.1.2.2 Low-flux dialyzers
9.3.2.1.2.2.1 Ability to filter small toxin particles to propel segment growth
9.3.2.1.2.2.2 Volume analysis of low-flux dialyzers, 2024-2031 (Ten Thousand Units)
9.3.2.2 Bloodline sets and tubes
9.3.2.2.1 High pricing and reduced rate of reuse to limit market expansion
9.3.2.2.2 Volume analysis of bloodline sets and tubes, 2024-2031 (Ten Thousand Units)
9.3.2.3 Concentrates/Dialysates
9.3.2.3.1 Alkaline concentrates
9.3.2.3.1.1 Growing consumption before dialysis to boost segment growth
9.3.2.3.1.2 Volume analysis of alkaline concentrates, 2024-2031 (Ten Thousand Units)
9.3.2.3.2 Acidic concentrates
9.3.2.3.2.1 Increased number of side effects to limit segment growth
9.3.2.3.2.2 Volume analysis of acidic concentrates, 2024-2031 (Ten Thousand Units)
9.3.2.4 Access products
9.3.2.4.1 AV fistula needles
9.3.2.4.1.1 Better blood flow and lower infection risk to aid segment growth
9.3.2.4.2 AV grafts
9.3.2.4.2.1 Increased number of patients requiring long-term dialysis to support segment growth
9.3.2.4.3 Central venous catheters
9.3.2.4.3.1 Increased use in temporary vascular access for short-term dialysis to boost segment growth
9.3.2.5 Other hemodialysis consumables & supplies
9.3.2.5.1 Volume analysis of other hemodialysis consumables, 2024-2031 (Ten Thousand Units)
9.4 HEMODIALYSIS MARKET, BY MODALITY
9.4.1 CONVENTIONAL HEMODIALYSIS
9.4.1.1 Technological advancements and rising number of dialysis centers to drive segment
9.4.2 SHORT DAILY HEMODIALYSIS
9.4.2.1 Improved blood pressure control and better calcium-phosphorus balance to augment segment growth
9.4.3 NOCTURNAL HEMODIALYSIS
9.4.3.1 Lower procedure costs to aid segment growth
9.5 HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, BY TYPE
9.5.1 CENTRAL WATER DISINFECTION SYSTEMS
9.5.1.1 Cost-effectiveness and easy maintenance to drive market
9.5.1.1.1 Volume analysis of central water disinfection systems, 2024-2031 (Ten Thousand Units)
9.5.2 PORTABLE WATER DISINFECTION SYSTEMS
9.5.2.1 User-friendly operations and improved microbiological purity to support segment growth
9.5.2.1.1 Volume analysis of portable water disinfection systems, 2024-2031 (Ten Thousand Units)
10 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE
10.1 INTRODUCTION
10.2 PERITONEAL DIALYSIS PRODUCTS
10.2.1 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES
10.2.1.1 High demand for concentrates to boost segment growth
10.2.1.1.1 Volume analysis of peritoneal dialysis concentrates/ dialysates, 2024-2031 (Ten Thousand Units)
10.2.2 PERITONEAL DIALYSIS MACHINES
10.2.2.1 Rising prevalence of chronic diseases in emerging economies to boost adoption
10.2.2.1.1 Volume analysis of peritoneal dialysis machines, 2024-2031 (Ten Thousand Units)
10.2.3 PERITONEAL DIALYSIS CATHETERS
10.2.3.1 Favorable reimbursement policies to support market growth
10.2.3.1.1 Volume analysis of peritoneal dialysis catheters, 2024-2031 (Ten Thousand Units)
10.2.4 PERITONEAL DIALYSIS TRANSFER SETS
10.2.4.1 Increasing number of patients in emerging economies to aid market growth
10.2.4.1.1 Volume analysis of peritoneal dialysis transfer sets, 2024-2031 (Ten Thousand Units)
10.2.5 OTHER PERITONEAL DIALYSIS PRODUCTS
10.2.5.1 Volume analysis of other peritoneal dialysis products, 2024-2031 (Ten Thousand Units)
10.3 PERITONEAL DIALYSIS SERVICES
10.3.1 BETTER PRIVACY AND INCREASED COMFORT OF AT-HOME DIALYSIS TREATMENT TO DRIVE MARKET
10.4 PERITONEAL DIALYSIS MARKET, BY MODALITY
10.4.1 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
10.4.1.1 Superior clearance of high-molecular-weight substances to drive market
10.4.2 AUTOMATED PERITONEAL DIALYSIS
10.4.2.1 Risk of rapid decline in residual renal functions to limit adoption
11 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION
11.1 INTRODUCTION
11.2 END-STAGE RENAL DISEASE
11.2.1 RISING GERIATRIC POPULATION AND INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET
11.3 ACUTE KIDNEY INJURY
11.3.1 INCREASING NUMBER OF HOSPITALIZATIONS TO PROPEL MARKET GROWTH
11.4 OTHER INDICATIONS
12 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER
12.1 INTRODUCTION
12.2 HOSPITALS
12.2.1 IMPROVED FACILITIES AND INCREASED GOVERNMENT SUPPORT TO DRIVE MARKET
12.3 INDEPENDENT DIALYSIS CENTERS
12.3.1 INCREASED DEMAND FOR ADVANCED DIALYSIS AND END-STAGE RENAL DISEASE TREATMENTS TO PROPEL MARKET GROWTH
12.4 HOME CARE SETTINGS
12.4.1 LOWER COST AND SHORTER HOSPITAL STAYS TO AID MARKET GROWTH
12.5 OTHER END USERS
13 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION
13.1 INTRODUCTION
13.2 NORTH AMERICA
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
13.2.2 NORTH AMERICA: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031
13.2.3 US
13.2.3.1 US to dominate North American market during study period
13.2.4 CANADA
13.2.4.1 Shortage of dialysis facilities and increased treatment cost to restrain market expansion
13.3 EUROPE
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
13.3.2 EUROPE: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031
13.3.3 GERMANY
13.3.3.1 Rising number of end-stage renal disease patients to boost market growth
13.3.4 UK
13.3.4.1 Expanding home dialysis programs and strong NHS support to drive market
13.3.5 FRANCE
13.3.5.1 Strong reimbursement framework and growing home dialysis adoption to fuel market
13.3.6 ITALY
13.3.6.1 Universal healthcare coverage and rising CKD burden to support market growth
13.3.7 SPAIN
13.3.7.1 Increasing CKD prevalence and expanding renal care infrastructure to drive market
13.3.8 REST OF EUROPE
13.4 ASIA PACIFIC
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
13.4.2 ASIA PACIFIC: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031
13.4.3 CHINA
13.4.3.1 Expanding dialysis infrastructure and large CKD patient base to drive market
13.4.4 JAPAN
13.4.4.1 Advanced dialysis infrastructure and universal reimbursement to support market growth
13.4.5 INDIA
13.4.5.1 Government-led dialysis expansion and rising CKD burden to fuel market
13.4.6 AUSTRALIA
13.4.6.1 High adoption of home dialysis and strong healthcare system to support market growth
13.4.7 SOUTH KOREA
13.4.7.1 Growing CKD burden and expanding renal care services to drive market
13.4.8 REST OF ASIA PACIFIC
13.5 LATIN AMERICA
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
13.5.2 LATIN AMERICA: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031
13.5.3 BRAZIL
13.5.3.1 Large dialysis patient base and expanding renal care infrastructure to drive market
13.5.4 MEXICO
13.5.4.1 Healthcare reforms and expanding access to dialysis to support market growth
13.5.5 REST OF LATIN AMERICA
13.6 MIDDLE EAST & AFRICA
13.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
13.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031
13.6.3 GCC COUNTRIES
13.6.3.1 Kingdom of Saudi Arabia (KSA)
13.6.3.1.1 Saudi Vision 2030 and expanding dialysis infrastructure to drive market
13.6.3.2 United Arab Emirates (UAE)
13.6.3.2.1 Growing investments in renal care and rising CKD burden to support market growth
13.6.3.3 Other GCC countries
13.6.4 REST OF MIDDLE EAST & AFRICA
14 COMPETITIVE LANDSCAPE
14.1 OVERVIEW
14.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023–JUNE 2026
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
14.3 REVENUE ANALYSIS
14.4 MARKET SHARE ANALYSIS
14.4.1 GLOBAL HEMODIALYSIS MARKET SHARE ANALYSIS, 2025
14.4.1.1 US hemodialysis market share analysis, 2025
14.4.1.2 Europe hemodialysis market share analysis, 2025
14.4.2 GLOBAL PERITONEAL DIALYSIS MARKET SHARE ANALYSIS, 2025
14.4.2.1 US peritoneal dialysis market share analysis, 2025
14.4.2.2 Europe peritoneal dialysis market share analysis, 2025
14.5 BRAND/PRODUCT COMPARISON
14.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
14.6.1 STARS
14.6.2 EMERGING LEADERS
14.6.3 PERVASIVE PLAYERS
14.6.4 PARTICIPANTS
14.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
14.6.5.1 Company footprint
14.6.5.2 Region footprint
14.6.5.3 Hemodialysis product & service footprint
14.6.5.4 Hemodialysis modality footprint
14.6.5.5 Hemodialysis water treatment system type footprint
14.6.5.6 Peritoneal dialysis product & service footprint
14.6.5.7 Peritoneal dialysis modality footprint
14.6.5.8 Hemodialysis and peritoneal dialysis application footprint
14.6.5.9 Hemodialysis and peritoneal dialysis end user footprint
14.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
14.7.1 PROGRESSIVE COMPANIES
14.7.2 RESPONSIVE COMPANIES
14.7.3 DYNAMIC COMPANIES
14.7.4 STARTING BLOCKS
14.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
14.7.5.1 Detailed list of key startups/SMEs
14.7.5.2 Competitive benchmarking of key startups/SMEs
14.8 COMPANY VALUATION AND FINANCIAL METRICS
14.8.1 COMPANY VALUATION
14.8.2 FINANCIAL METRICS
14.9 COMPETITIVE SCENARIO
14.9.1 PRODUCT LAUNCHES & APPROVALS
14.9.2 DEALS
14.9.3 EXPANSIONS
14.9.4 OTHER DEVELOPMENTS
15 COMPANY PROFILES
15.1 KEY PLAYERS
15.1.1 FRESENIUS MEDICAL CARE AG
15.1.1.1 Business overview
15.1.1.2 Products/Solutions/Services offered
15.1.1.3 Recent developments
15.1.1.3.1 Product launches & approvals
15.1.1.3.2 Deals
15.1.1.3.3 Expansions
15.1.1.3.4 Other developments
15.1.1.4 MnM view
15.1.1.4.1 Key strengths
15.1.1.4.2 Strategic choices
15.1.1.4.3 Weaknesses & competitive threats
15.1.2 DAVITA INC.
15.1.2.1 Business overview
15.1.2.2 Products/Solutions/Services offered
15.1.2.3 Recent developments
15.1.2.3.1 Deals
15.1.2.4 MnM view
15.1.2.4.1 Key strengths
15.1.2.4.2 Strategic choices
15.1.2.4.3 Weaknesses & competitive threats
15.1.3 VANTIVE
15.1.3.1 Business overview
15.1.3.2 Products/Solutions/Services offered
15.1.3.3 Recent developments
15.1.3.3.1 Product launches & approvals
15.1.3.3.2 Deals
15.1.3.3.3 Expansions
15.1.3.3.4 Other developments
15.1.3.4 MnM view
15.1.3.4.1 Key strengths
15.1.3.4.2 Strategic choices
15.1.3.4.3 Weaknesses & competitive threats
15.1.4 U.S. RENAL CARE, INC.
15.1.4.1 Business overview
15.1.4.2 Products/Solutions/Services offered
15.1.4.3 MnM view
15.1.4.3.1 Key strengths
15.1.4.3.2 Strategic choices
15.1.4.3.3 Weaknesses & competitive threats
15.1.5 B. BRAUN SE
15.1.5.1 Business overview
15.1.5.2 Products/Solutions/Services offered
15.1.5.3 Recent developments
15.1.5.3.1 Expansions
15.1.5.4 MnM view
15.1.5.4.1 Key strengths
15.1.5.4.2 Strategic choices
15.1.5.4.3 Weaknesses & competitive threats
15.1.6 NIPRO CORPORATION
15.1.6.1 Business overview
15.1.6.2 Products/Solutions/Services offered
15.1.6.3 Recent developments
15.1.6.3.1 Product launches & approvals
15.1.6.3.2 Deals
15.1.6.3.3 Expansions
15.1.7 DIAVERUM AB
15.1.7.1 Business overview
15.1.7.2 Products/Solutions/Services offered
15.1.7.3 Recent developments
15.1.7.3.1 Deals
15.1.7.3.2 Expansions
15.1.8 ASAHI KASEI MEDICAL CO., LTD.
15.1.8.1 Business overview
15.1.8.2 Products/Solutions/Services offered
15.1.8.3 Recent developments
15.1.8.3.1 Deals
15.1.8.3.2 Other developments
15.1.9 TORAY INDUSTRIES, INC.
15.1.9.1 Business overview
15.1.9.2 Products/Solutions/Services offered
15.1.10 NIKKISO CO., LTD.
15.1.10.1 Business overview
15.1.10.2 Products/Solutions/Services offered
15.1.10.3 Recent developments
15.1.10.3.1 Product launches & approvals
15.1.10.3.2 Deals
15.1.11 MOZARC MEDICAL
15.1.11.1 Business overview
15.1.11.2 Products/Solutions/Services offered
15.1.11.3 Recent developments
15.1.11.3.1 Deals
15.1.12 BD
15.1.12.1 Business overview
15.1.12.2 Products/Solutions/Services offered
15.1.12.3 Recent developments
15.1.12.3.1 Deals
15.1.12.3.2 Expansions
15.1.13 JMS CO., LTD.
15.1.13.1 Business overview
15.1.13.2 Products/Solutions/Services offered
15.1.14 MERIT MEDICAL SYSTEMS
15.1.14.1 Business overview
15.1.14.2 Products/Solutions/Services offered
15.1.14.3 Recent developments
15.1.14.3.1 Deals
15.1.15 TERUMO CORPORATION
15.1.15.1 Business overview
15.1.15.2 Products/Solutions/Services offered
15.2 OTHER PLAYERS
15.2.1 ALLMED MEDICAL PRODUCTS CO., LTD.
15.2.2 OUTSET MEDICAL, INC.
15.2.3 ROCKWELL MEDICAL, INC.
15.2.4 AMERIWATER LLC
15.2.5 DIALIFE SA
15.2.6 QUANTA DIALYSIS TECHNOLOGIES LTD
15.2.7 ISOPURE CORP.
15.2.8 POLY MEDICURE LIMITED
15.2.9 ATLANTIC BIOMEDICAL
15.2.10 AMECATH
16 RESEARCH METHODOLOGY
16.1 RESEARCH DATA
16.1.1 SECONDARY DATA
16.1.1.1 Key secondary sources
16.1.2 PRIMARY DATA
16.1.2.1 Primary sources
16.1.2.2 Key data from primary sources
16.1.2.3 Key industry insights
16.1.2.4 Breakdown of primaries
16.2 MARKET SIZE ESTIMATION
16.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
16.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
16.2.3 APPROACH 3: TOP-DOWN APPROACH
16.2.4 APPROACH 4: BOTTOM-UP APPROACH
16.2.5 APPROACH 4: PRIMARY INTERVIEWS
16.2.6 APPROACH 5: DEMAND-SIDE APPROACH
16.2.7 APPROACH 6: VOLUME DATA ANALYSIS
16.3 DATA TRIANGULATION AND MARKET BREAKDOWN
16.4 MARKET SHARE ASSESSMENT
16.5 RESEARCH ASSUMPTIONS
16.5.1 STUDY ASSUMPTIONS
16.5.2 GROWTH RATE ASSUMPTIONS
16.6 RISK ASSESSMENT
16.7 RESEARCH LIMITATIONS
17 APPENDIX
17.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.2 CUSTOMIZATION OPTIONS
17.2.1 PRODUCT ANALYSIS
17.2.2 COMPANY INFORMATION
17.2.3 GEOGRAPHIC ANALYSIS
17.3 RELATED REPORTS
17.4 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 STANDARD CURRENCY CONVERSION RATES
TABLE 2 AGE DISTRIBUTION OF KIDNEY CARE PATIENTS IN BRITISH COLUMBIA, BY TREATMENT MODALITY
TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
TABLE 4 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION)
TABLE 5 LIST OF KEY HEMODIALYSIS AND PERITONEAL DIALYSIS MANUFACTURERS
TABLE 6 LIST OF KEY END USERS
TABLE 7 LIST OF KEY REGULATORY BODIES
TABLE 8 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2023–2025 (USD)
TABLE 9 AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 (USD)
TABLE 10 IMPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 11 EXPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 12 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 13 HOME PERITONEAL DIALYSIS WITH REMOTE PATIENT MONITORING
TABLE 14 HOME HEMODIALYSIS SUPPORTING FULL-TIME EMPLOYMENT
TABLE 15 HOME PERITONEAL DIALYSIS FOR VISUALLY IMPAIRED PATIENT
TABLE 16 RECIPROCAL TARIFF RATES ADJUSTED BY US, 2025
TABLE 17 KEY PRODUCT-RELATED TARIFFS
TABLE 18 NORTH AMERICA: IMPACT OF US TARIFF ON CANADA
TABLE 19 ASIA PACIFIC: IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA
TABLE 20 EUROPE: IMPACT OF US TARIFF ON GERMANY AND UK
TABLE 21 LATIN AMERICA: IMPACT OF US TARIFF ON MEXICO
TABLE 22 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: KEY PATENTS, 2023–2025
TABLE 23 COMPANIES IMPLEMENTING AI
TABLE 24 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 27 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 28 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
TABLE 30 KEY BUYING CRITERIA FOR END USERS
TABLE 31 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: ADOPTION BARRIERS AND INTERNAL CHALLENGES
TABLE 32 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
TABLE 33 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: KEY PROFITABILITY DRIVERS
TABLE 34 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 35 HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 36 HEMODIALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 37 KEY PLAYERS PROVIDING IN—CENTER HEMODIALYSIS SERVICES
TABLE 38 IN-CENTER HEMODIALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 39 KEY PLAYERS PROVIDING HOME HEMODIALYSIS SERVICES
TABLE 40 HOME HEMODIALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 41 HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 42 HEMODIALYSIS PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 43 HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 44 HEMODIALYSIS MACHINES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 45 KEY PLAYERS PROVIDING CENTER-USE HEMODIALYSIS MACHINES
TABLE 46 CENTER-USE HEMODIALYSIS MACHINES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 47 CENTER-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 48 KEY PLAYERS PROVIDING HOME-USE HEMODIALYSIS MACHINES
TABLE 49 HOME-USE HEMODIALYSIS MACHINES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 50 HOME-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 51 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 52 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 53 DIALYZERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 54 DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 55 KEY PLAYERS PROVIDING SYNTHETIC DIALYZERS
TABLE 56 SYNTHETIC DIALYZERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 57 SYNTHETIC DIALYZERS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 58 KEY PLAYERS PROVIDING CELLULOSE-BASED DIALYZERS
TABLE 59 CELLULOSE-BASED DIALYZERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 60 CELLULOSE-BASED DIALYZERS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 61 DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 62 KEY PLAYERS PROVIDING HIGH-FLUX DIALYZERS
TABLE 63 HIGH-FLUX DIALYZERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 64 HIGH-FLUX DIALYZERS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 65 KEY PLAYERS PROVIDING LOW-FLUX DIALYZERS
TABLE 66 LOW-FLUX DIALYZERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 67 LOW-FLUX DIALYZERS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 68 KEY PLAYERS PROVIDING BLOODLINE SETS AND TUBES
TABLE 69 BLOODLINE SETS AND TUBES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 70 BLOODLINE SETS AND TUBES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 71 CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 72 CONCENTRATES/DIALYSATES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 73 KEY PLAYERS PROVIDING ALKALINE CONCENTRATES
TABLE 74 ALKALINE CONCENTRATES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 75 ALKALINE CONCENTRATES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 76 KEY PLAYERS PROVIDING ACIDIC CONCENTRATES
TABLE 77 ACIDIC CONCENTRATES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 78 ACIDIC CONCENTRATES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 79 ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 80 ACCESS PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 81 KEY PLAYERS PROVIDING AV FISTULA NEEDLES
TABLE 82 AV FISTULA NEEDLES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 83 KEY PLAYERS PROVIDING AV GRAFTS
TABLE 84 AV GRAFTS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 85 KEY PLAYERS PROVIDING CENTRAL VENOUS CATHETERS
TABLE 86 CENTRAL VENOUS CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 87 KEY PLAYERS PROVIDING OTHER HEMODIALYSIS CONSUMABLES & SUPPLIES
TABLE 88 OTHER HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 89 OTHER HEMODIALYSIS CONSUMABLES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 90 HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 91 HEMODIALYSIS MARKET FOR CONVENTIONAL HEMODIALYSIS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 92 HEMODIALYSIS MARKET FOR SHORT DAILY HEMODIALYSIS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 93 HEMODIALYSIS MARKET FOR NOCTURNAL HEMODIALYSIS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 94 HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 95 HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 96 KEY PLAYERS PROVIDING CENTRAL WATER DISINFECTION SYSTEMS
TABLE 97 CENTRAL WATER DISINFECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 98 CENTRAL WATER DISINFECTION SYSTEMS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 99 KEY PLAYERS PROVIDING PORTABLE WATER DISINFECTION SYSTEMS
TABLE 100 PORTABLE WATER DISINFECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 101 PORTABLE WATER DISINFECTION SYSTEMS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 102 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 103 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2024–2031 (USD BILLION)
TABLE 104 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 105 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES
TABLE 106 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 107 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 108 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS MACHINES
TABLE 109 PERITONEAL DIALYSIS MACHINES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 110 PERITONEAL DIALYSIS MACHINES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 111 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS CATHETERS
TABLE 112 PERITONEAL DIALYSIS CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 113 PERITONEAL DIALYSIS CATHETERS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 114 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS TRANSFER SETS
TABLE 115 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 116 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 117 KEY PLAYERS PROVIDING OTHER PERITONEAL DIALYSIS PRODUCTS
TABLE 118 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 119 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 120 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS SERVICES
TABLE 121 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS SERVICES, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 122 PERITONEAL DIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 123 PERITONEAL DIALYSIS MARKET FOR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 124 PERITONEAL DIALYSIS MARKET FOR AUTOMATED PERITONEAL DIALYSIS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 125 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 126 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR END-STAGE RENAL DISEASE, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 127 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR ACUTE KIDNEY INJURY, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 128 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 129 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 130 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 131 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR INDEPENDENT DIALYSIS CENTERS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 132 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 133 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 134 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION, 2024–2031 (USD BILLION)
TABLE 135 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (TEN THOUSAND UNITS)
TABLE 136 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 137 NORTH AMERICA: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 138 NORTH AMERICA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 139 NORTH AMERICA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 140 NORTH AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 141 NORTH AMERICA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 142 NORTH AMERICA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 143 NORTH AMERICA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 144 NORTH AMERICA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 145 NORTH AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 146 NORTH AMERICA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 147 NORTH AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 148 NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 149 NORTH AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 150 NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 151 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 152 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 153 US: MACROECONOMIC INDICATORS
TABLE 154 US: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 155 US: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 156 US: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 157 US: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 158 US: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 159 US: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 160 US: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 161 US: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 162 US: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 163 US: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 164 US: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 165 US: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 166 US: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 167 US: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 168 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 169 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 170 CANADA: MACROECONOMIC INDICATORS
TABLE 171 CANADA: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 172 CANADA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 173 CANADA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 174 CANADA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 175 CANADA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 176 CANADA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 177 CANADA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 178 CANADA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 179 CANADA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 180 CANADA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 181 CANADA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 182 CANADA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 183 CANADA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 184 CANADA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 185 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 186 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 187 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (TEN THOUSAND UNITS)
TABLE 188 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 189 EUROPE: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 190 EUROPE: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 191 EUROPE: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 192 EUROPE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 193 EUROPE: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 194 EUROPE: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 195 EUROPE: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 196 EUROPE: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 197 EUROPE: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 198 EUROPE: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 199 EUROPE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 200 EUROPE: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 201 EUROPE: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 202 EUROPE: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 203 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 204 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 205 GERMANY: MACROECONOMIC INDICATORS
TABLE 206 GERMANY: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 207 GERMANY: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 208 GERMANY: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 209 GERMANY: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 210 GERMANY: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 211 GERMANY: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 212 GERMANY: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 213 GERMANY: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 214 GERMANY: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 215 GERMANY: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 216 GERMANY: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 217 GERMANY: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 218 GERMANY: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 219 GERMANY: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 220 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 221 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 222 UK: MACROECONOMIC INDICATORS
TABLE 223 UK: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 224 UK: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 225 UK: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 226 UK: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 227 UK: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 228 UK: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 229 UK: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 230 UK: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 231 UK: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 232 UK: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 233 UK: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 234 UK: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 235 UK: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 236 UK: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 237 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 238 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 239 FRANCE: MACROECONOMIC INDICATORS
TABLE 240 FRANCE: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 241 FRANCE: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 242 FRANCE: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 243 FRANCE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 244 FRANCE: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 245 FRANCE: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 246 FRANCE: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 247 FRANCE: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 248 FRANCE: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 249 FRANCE: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 250 FRANCE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 251 FRANCE: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 252 FRANCE: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 253 FRANCE: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 254 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 255 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 256 ITALY: MACROECONOMIC INDICATORS
TABLE 257 ITALY: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 258 ITALY: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 259 ITALY: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 260 ITALY: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 261 ITALY: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 262 ITALY: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 263 ITALY: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 264 ITALY: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 265 ITALY: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 266 ITALY: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 267 ITALY: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 268 ITALY: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 269 ITALY: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 270 ITALY: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 271 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 272 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 273 SPAIN: MACROECONOMIC INDICATORS
TABLE 274 SPAIN: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 275 SPAIN: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 276 SPAIN: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 277 SPAIN: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 278 SPAIN: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 279 SPAIN: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 280 SPAIN: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 281 SPAIN: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 282 SPAIN: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 283 SPAIN: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 284 SPAIN: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 285 SPAIN: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 286 SPAIN: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 287 SPAIN: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 288 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 289 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 290 REST OF EUROPE: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 291 REST OF EUROPE: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 292 REST OF EUROPE: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 293 REST OF EUROPE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 294 REST OF EUROPE: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 295 REST OF EUROPE: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 296 REST OF EUROPE: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 297 REST OF EUROPE: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 298 REST OF EUROPE: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 299 REST OF EUROPE: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 300 REST OF EUROPE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 301 REST OF EUROPE: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 302 REST OF EUROPE: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 303 REST OF EUROPE: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 304 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 305 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 306 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (TEN THOUSAND UNITS)
TABLE 307 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 308 ASIA PACIFIC: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 309 ASIA PACIFIC: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 310 ASIA PACIFIC: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 311 ASIA PACIFIC: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 312 ASIA PACIFIC: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 313 ASIA PACIFIC: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 314 ASIA PACIFIC: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 315 ASIA PACIFIC: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 316 ASIA PACIFIC: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 317 ASIA PACIFIC: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 318 ASIA PACIFIC: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 319 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 320 ASIA PACIFIC: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 321 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 322 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 323 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 324 CHINA: MACROECONOMIC INDICATORS
TABLE 325 CHINA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 326 CHINA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 327 CHINA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 328 CHINA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 329 CHINA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 330 CHINA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 331 CHINA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 332 CHINA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 333 CHINA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 334 CHINA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 335 CHINA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 336 CHINA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 337 CHINA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 338 CHINA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 339 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 340 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 1 STANDARD CURRENCY CONVERSION RATES
TABLE 2 AGE DISTRIBUTION OF KIDNEY CARE PATIENTS IN BRITISH COLUMBIA, BY TREATMENT MODALITY
TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
TABLE 4 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION)
TABLE 5 LIST OF KEY HEMODIALYSIS AND PERITONEAL DIALYSIS MANUFACTURERS
TABLE 6 LIST OF KEY END USERS
TABLE 7 LIST OF KEY REGULATORY BODIES
TABLE 8 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2023–2025 (USD)
TABLE 9 AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 (USD)
TABLE 10 IMPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 11 EXPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 12 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 13 HOME PERITONEAL DIALYSIS WITH REMOTE PATIENT MONITORING
TABLE 14 HOME HEMODIALYSIS SUPPORTING FULL-TIME EMPLOYMENT
TABLE 15 HOME PERITONEAL DIALYSIS FOR VISUALLY IMPAIRED PATIENT
TABLE 16 RECIPROCAL TARIFF RATES ADJUSTED BY US, 2025
TABLE 17 KEY PRODUCT-RELATED TARIFFS
TABLE 18 NORTH AMERICA: IMPACT OF US TARIFF ON CANADA
TABLE 19 ASIA PACIFIC: IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA
TABLE 20 EUROPE: IMPACT OF US TARIFF ON GERMANY AND UK
TABLE 21 LATIN AMERICA: IMPACT OF US TARIFF ON MEXICO
TABLE 22 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: KEY PATENTS, 2023–2025
TABLE 23 COMPANIES IMPLEMENTING AI
TABLE 24 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 27 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 28 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
TABLE 30 KEY BUYING CRITERIA FOR END USERS
TABLE 31 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: ADOPTION BARRIERS AND INTERNAL CHALLENGES
TABLE 32 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
TABLE 33 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: KEY PROFITABILITY DRIVERS
TABLE 34 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 35 HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 36 HEMODIALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 37 KEY PLAYERS PROVIDING IN—CENTER HEMODIALYSIS SERVICES
TABLE 38 IN-CENTER HEMODIALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 39 KEY PLAYERS PROVIDING HOME HEMODIALYSIS SERVICES
TABLE 40 HOME HEMODIALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 41 HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 42 HEMODIALYSIS PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 43 HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 44 HEMODIALYSIS MACHINES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 45 KEY PLAYERS PROVIDING CENTER-USE HEMODIALYSIS MACHINES
TABLE 46 CENTER-USE HEMODIALYSIS MACHINES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 47 CENTER-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 48 KEY PLAYERS PROVIDING HOME-USE HEMODIALYSIS MACHINES
TABLE 49 HOME-USE HEMODIALYSIS MACHINES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 50 HOME-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 51 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 52 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 53 DIALYZERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 54 DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 55 KEY PLAYERS PROVIDING SYNTHETIC DIALYZERS
TABLE 56 SYNTHETIC DIALYZERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 57 SYNTHETIC DIALYZERS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 58 KEY PLAYERS PROVIDING CELLULOSE-BASED DIALYZERS
TABLE 59 CELLULOSE-BASED DIALYZERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 60 CELLULOSE-BASED DIALYZERS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 61 DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 62 KEY PLAYERS PROVIDING HIGH-FLUX DIALYZERS
TABLE 63 HIGH-FLUX DIALYZERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 64 HIGH-FLUX DIALYZERS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 65 KEY PLAYERS PROVIDING LOW-FLUX DIALYZERS
TABLE 66 LOW-FLUX DIALYZERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 67 LOW-FLUX DIALYZERS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 68 KEY PLAYERS PROVIDING BLOODLINE SETS AND TUBES
TABLE 69 BLOODLINE SETS AND TUBES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 70 BLOODLINE SETS AND TUBES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 71 CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 72 CONCENTRATES/DIALYSATES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 73 KEY PLAYERS PROVIDING ALKALINE CONCENTRATES
TABLE 74 ALKALINE CONCENTRATES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 75 ALKALINE CONCENTRATES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 76 KEY PLAYERS PROVIDING ACIDIC CONCENTRATES
TABLE 77 ACIDIC CONCENTRATES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 78 ACIDIC CONCENTRATES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 79 ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 80 ACCESS PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 81 KEY PLAYERS PROVIDING AV FISTULA NEEDLES
TABLE 82 AV FISTULA NEEDLES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 83 KEY PLAYERS PROVIDING AV GRAFTS
TABLE 84 AV GRAFTS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 85 KEY PLAYERS PROVIDING CENTRAL VENOUS CATHETERS
TABLE 86 CENTRAL VENOUS CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 87 KEY PLAYERS PROVIDING OTHER HEMODIALYSIS CONSUMABLES & SUPPLIES
TABLE 88 OTHER HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 89 OTHER HEMODIALYSIS CONSUMABLES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 90 HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 91 HEMODIALYSIS MARKET FOR CONVENTIONAL HEMODIALYSIS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 92 HEMODIALYSIS MARKET FOR SHORT DAILY HEMODIALYSIS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 93 HEMODIALYSIS MARKET FOR NOCTURNAL HEMODIALYSIS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 94 HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 95 HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 96 KEY PLAYERS PROVIDING CENTRAL WATER DISINFECTION SYSTEMS
TABLE 97 CENTRAL WATER DISINFECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 98 CENTRAL WATER DISINFECTION SYSTEMS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 99 KEY PLAYERS PROVIDING PORTABLE WATER DISINFECTION SYSTEMS
TABLE 100 PORTABLE WATER DISINFECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 101 PORTABLE WATER DISINFECTION SYSTEMS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 102 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 103 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2024–2031 (USD BILLION)
TABLE 104 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 105 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES
TABLE 106 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 107 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 108 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS MACHINES
TABLE 109 PERITONEAL DIALYSIS MACHINES MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 110 PERITONEAL DIALYSIS MACHINES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 111 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS CATHETERS
TABLE 112 PERITONEAL DIALYSIS CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 113 PERITONEAL DIALYSIS CATHETERS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 114 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS TRANSFER SETS
TABLE 115 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 116 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 117 KEY PLAYERS PROVIDING OTHER PERITONEAL DIALYSIS PRODUCTS
TABLE 118 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 119 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS)
TABLE 120 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS SERVICES
TABLE 121 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS SERVICES, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 122 PERITONEAL DIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 123 PERITONEAL DIALYSIS MARKET FOR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 124 PERITONEAL DIALYSIS MARKET FOR AUTOMATED PERITONEAL DIALYSIS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 125 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 126 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR END-STAGE RENAL DISEASE, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 127 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR ACUTE KIDNEY INJURY, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 128 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 129 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 130 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 131 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR INDEPENDENT DIALYSIS CENTERS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 132 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 133 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 134 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION, 2024–2031 (USD BILLION)
TABLE 135 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (TEN THOUSAND UNITS)
TABLE 136 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 137 NORTH AMERICA: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 138 NORTH AMERICA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 139 NORTH AMERICA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 140 NORTH AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 141 NORTH AMERICA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 142 NORTH AMERICA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 143 NORTH AMERICA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 144 NORTH AMERICA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 145 NORTH AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 146 NORTH AMERICA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 147 NORTH AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 148 NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 149 NORTH AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 150 NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 151 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 152 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 153 US: MACROECONOMIC INDICATORS
TABLE 154 US: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 155 US: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 156 US: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 157 US: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 158 US: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 159 US: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 160 US: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 161 US: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 162 US: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 163 US: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 164 US: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 165 US: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 166 US: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 167 US: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 168 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 169 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 170 CANADA: MACROECONOMIC INDICATORS
TABLE 171 CANADA: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 172 CANADA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 173 CANADA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 174 CANADA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 175 CANADA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 176 CANADA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 177 CANADA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 178 CANADA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 179 CANADA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 180 CANADA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 181 CANADA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 182 CANADA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 183 CANADA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 184 CANADA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 185 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 186 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 187 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (TEN THOUSAND UNITS)
TABLE 188 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 189 EUROPE: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 190 EUROPE: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 191 EUROPE: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 192 EUROPE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 193 EUROPE: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 194 EUROPE: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 195 EUROPE: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 196 EUROPE: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 197 EUROPE: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 198 EUROPE: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 199 EUROPE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 200 EUROPE: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 201 EUROPE: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 202 EUROPE: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 203 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 204 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 205 GERMANY: MACROECONOMIC INDICATORS
TABLE 206 GERMANY: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 207 GERMANY: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 208 GERMANY: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 209 GERMANY: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 210 GERMANY: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 211 GERMANY: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 212 GERMANY: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 213 GERMANY: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 214 GERMANY: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 215 GERMANY: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 216 GERMANY: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 217 GERMANY: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 218 GERMANY: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 219 GERMANY: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 220 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 221 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 222 UK: MACROECONOMIC INDICATORS
TABLE 223 UK: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 224 UK: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 225 UK: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 226 UK: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 227 UK: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 228 UK: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 229 UK: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 230 UK: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 231 UK: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 232 UK: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 233 UK: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 234 UK: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 235 UK: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 236 UK: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 237 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 238 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 239 FRANCE: MACROECONOMIC INDICATORS
TABLE 240 FRANCE: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 241 FRANCE: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 242 FRANCE: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 243 FRANCE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 244 FRANCE: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 245 FRANCE: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 246 FRANCE: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 247 FRANCE: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 248 FRANCE: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 249 FRANCE: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 250 FRANCE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 251 FRANCE: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 252 FRANCE: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 253 FRANCE: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 254 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 255 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 256 ITALY: MACROECONOMIC INDICATORS
TABLE 257 ITALY: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 258 ITALY: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 259 ITALY: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 260 ITALY: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 261 ITALY: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 262 ITALY: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 263 ITALY: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 264 ITALY: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 265 ITALY: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 266 ITALY: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 267 ITALY: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 268 ITALY: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 269 ITALY: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 270 ITALY: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 271 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 272 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 273 SPAIN: MACROECONOMIC INDICATORS
TABLE 274 SPAIN: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 275 SPAIN: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 276 SPAIN: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 277 SPAIN: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 278 SPAIN: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 279 SPAIN: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 280 SPAIN: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 281 SPAIN: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 282 SPAIN: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 283 SPAIN: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 284 SPAIN: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 285 SPAIN: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 286 SPAIN: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 287 SPAIN: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 288 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 289 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 290 REST OF EUROPE: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 291 REST OF EUROPE: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 292 REST OF EUROPE: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 293 REST OF EUROPE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 294 REST OF EUROPE: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 295 REST OF EUROPE: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 296 REST OF EUROPE: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 297 REST OF EUROPE: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 298 REST OF EUROPE: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 299 REST OF EUROPE: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 300 REST OF EUROPE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 301 REST OF EUROPE: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 302 REST OF EUROPE: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 303 REST OF EUROPE: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 304 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 305 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 306 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (TEN THOUSAND UNITS)
TABLE 307 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024–2031 (USD BILLION)
TABLE 308 ASIA PACIFIC: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 309 ASIA PACIFIC: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 310 ASIA PACIFIC: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 311 ASIA PACIFIC: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 312 ASIA PACIFIC: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 313 ASIA PACIFIC: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 314 ASIA PACIFIC: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 315 ASIA PACIFIC: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 316 ASIA PACIFIC: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 317 ASIA PACIFIC: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 318 ASIA PACIFIC: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 319 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 320 ASIA PACIFIC: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 321 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 322 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 323 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
TABLE 324 CHINA: MACROECONOMIC INDICATORS
TABLE 325 CHINA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 326 CHINA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 327 CHINA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 328 CHINA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 329 CHINA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 330 CHINA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION)
TABLE 331 CHINA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION)
TABLE 332 CHINA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 333 CHINA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION)
TABLE 334 CHINA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 335 CHINA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 336 CHINA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION)
TABLE 337 CHINA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 338 CHINA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION)
TABLE 339 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION)
TABLE 340 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION)
LIST OF FIGURES
FIGURE 1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SEGMENTATION
FIGURE 2 MARKET SCENARIO
FIGURE 3 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, 2024–2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, 2023–2025
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, 2026–2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 8 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET TRENDS SIGNAL STRONG FUTURE FOR HOME-BASED AND ADVANCED DIALYSIS THERAPIES
FIGURE 9 INDEPENDENT DIALYSIS CENTERS SEGMENT AND CHINA DOMINATED MARKET IN 2025
FIGURE 10 CHINA TO REGISTER HIGHEST CAGR FROM 2026 TO 2031
FIGURE 11 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 12 PERCENTAGE OF US ADULTS AGED 18 YEARS AND OLDER WITH CKD, BY AGE, SEX, AND RACE-ETHNICITY
FIGURE 13 PERCENTAGE OF CKD AMONG US ADULTS WITH DIABETES AGED 18 YEARS OR OLDER, BY AGE, SEX, AND RACE/ETHNICITY
FIGURE 14 PERCENTAGE OF CKD AMONG US ADULTS WITH HIGH BLOOD PRESSURE AGED 18 YEARS OR OLDER, BY AGE, SEX, AND RACE/ETHNICITY
FIGURE 15 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 16 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 17 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: VALUE CHAIN ANALYSIS
FIGURE 18 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET ECOSYSTEM
FIGURE 19 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2025 (USD)
FIGURE 20 AVERAGE SELLING PRICE, BY REGION, 2025 (USD)
FIGURE 21 REVENUE SHIFT AND NEW REVENUE POCKETS FOR HEMODIALYSIS AND PERITONEAL DIALYSIS DEVICES MARKET
FIGURE 22 INVESTMENT AND FUNDING SCENARIO
FIGURE 23 PATENTS APPLIED AND GRANTED, 2015–JUNE 2026
FIGURE 24 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: AI USE CASES
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
FIGURE 26 KEY BUYING CRITERIA FOR END USERS
FIGURE 27 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
FIGURE 28 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET (2023?2025)
FIGURE 30 GLOBAL HEMODIALYSIS MARKET SHARE, 2025
FIGURE 31 US HEMODIALYSIS MARKET SHARE, 2025
FIGURE 32 EUROPE HEMODIALYSIS MARKET SHARE, 2025
FIGURE 33 GLOBAL PERITONEAL DIALYSIS MARKET SHARE, 2025
FIGURE 34 US PERITONEAL DIALYSIS MARKET SHARE, 2025
FIGURE 35 EUROPE PERITONEAL DIALYSIS MARKET SHARE, 2025
FIGURE 36 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 37 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 38 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY FOOTPRINT (1/2)
FIGURE 39 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY FOOTPRINT (2/2)
FIGURE 40 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 42 EV/EBITDA OF KEY VENDORS
FIGURE 43 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT (2025)
FIGURE 44 DAVITA INC.: COMPANY SNAPSHOT (2025)
FIGURE 45 B. BRAUN SE: COMPANY SNAPSHOT (2025)
FIGURE 46 NIPRO CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 47 TORAY INDUSTRIES, INC.: COMPANY SNAPSHOT (2025)
FIGURE 48 NIKKISO CO., LTD.: COMPANY SNAPSHOT (2025)
FIGURE 49 BD: COMPANY SNAPSHOT (2025)
FIGURE 50 JMS CO., LTD.: COMPANY SNAPSHOT (2025)
FIGURE 51 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2025)
FIGURE 52 TERUMO CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 53 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: RESEARCH DESIGN
FIGURE 54 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 55 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 56 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
FIGURE 57 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 58 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS
FIGURE 59 REVENUE SHARE ANALYSIS ILLUSTRATION: B BRAUN (2025)
FIGURE 60 TOP-DOWN APPROACH
FIGURE 61 BOTTOM-UP APPROACH
FIGURE 62 DEMAND-SIDE APPROACH
FIGURE 63 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET (2026–2031)
FIGURE 64 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 65 DATA TRIANGULATION METHODOLOGY
FIGURE 1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SEGMENTATION
FIGURE 2 MARKET SCENARIO
FIGURE 3 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, 2024–2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, 2023–2025
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, 2026–2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 8 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET TRENDS SIGNAL STRONG FUTURE FOR HOME-BASED AND ADVANCED DIALYSIS THERAPIES
FIGURE 9 INDEPENDENT DIALYSIS CENTERS SEGMENT AND CHINA DOMINATED MARKET IN 2025
FIGURE 10 CHINA TO REGISTER HIGHEST CAGR FROM 2026 TO 2031
FIGURE 11 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 12 PERCENTAGE OF US ADULTS AGED 18 YEARS AND OLDER WITH CKD, BY AGE, SEX, AND RACE-ETHNICITY
FIGURE 13 PERCENTAGE OF CKD AMONG US ADULTS WITH DIABETES AGED 18 YEARS OR OLDER, BY AGE, SEX, AND RACE/ETHNICITY
FIGURE 14 PERCENTAGE OF CKD AMONG US ADULTS WITH HIGH BLOOD PRESSURE AGED 18 YEARS OR OLDER, BY AGE, SEX, AND RACE/ETHNICITY
FIGURE 15 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 16 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 17 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: VALUE CHAIN ANALYSIS
FIGURE 18 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET ECOSYSTEM
FIGURE 19 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2025 (USD)
FIGURE 20 AVERAGE SELLING PRICE, BY REGION, 2025 (USD)
FIGURE 21 REVENUE SHIFT AND NEW REVENUE POCKETS FOR HEMODIALYSIS AND PERITONEAL DIALYSIS DEVICES MARKET
FIGURE 22 INVESTMENT AND FUNDING SCENARIO
FIGURE 23 PATENTS APPLIED AND GRANTED, 2015–JUNE 2026
FIGURE 24 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: AI USE CASES
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
FIGURE 26 KEY BUYING CRITERIA FOR END USERS
FIGURE 27 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
FIGURE 28 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET (2023?2025)
FIGURE 30 GLOBAL HEMODIALYSIS MARKET SHARE, 2025
FIGURE 31 US HEMODIALYSIS MARKET SHARE, 2025
FIGURE 32 EUROPE HEMODIALYSIS MARKET SHARE, 2025
FIGURE 33 GLOBAL PERITONEAL DIALYSIS MARKET SHARE, 2025
FIGURE 34 US PERITONEAL DIALYSIS MARKET SHARE, 2025
FIGURE 35 EUROPE PERITONEAL DIALYSIS MARKET SHARE, 2025
FIGURE 36 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 37 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 38 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY FOOTPRINT (1/2)
FIGURE 39 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY FOOTPRINT (2/2)
FIGURE 40 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 42 EV/EBITDA OF KEY VENDORS
FIGURE 43 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT (2025)
FIGURE 44 DAVITA INC.: COMPANY SNAPSHOT (2025)
FIGURE 45 B. BRAUN SE: COMPANY SNAPSHOT (2025)
FIGURE 46 NIPRO CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 47 TORAY INDUSTRIES, INC.: COMPANY SNAPSHOT (2025)
FIGURE 48 NIKKISO CO., LTD.: COMPANY SNAPSHOT (2025)
FIGURE 49 BD: COMPANY SNAPSHOT (2025)
FIGURE 50 JMS CO., LTD.: COMPANY SNAPSHOT (2025)
FIGURE 51 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2025)
FIGURE 52 TERUMO CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 53 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: RESEARCH DESIGN
FIGURE 54 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 55 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 56 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
FIGURE 57 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 58 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS
FIGURE 59 REVENUE SHARE ANALYSIS ILLUSTRATION: B BRAUN (2025)
FIGURE 60 TOP-DOWN APPROACH
FIGURE 61 BOTTOM-UP APPROACH
FIGURE 62 DEMAND-SIDE APPROACH
FIGURE 63 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET (2026–2031)
FIGURE 64 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 65 DATA TRIANGULATION METHODOLOGY
